202 related articles for article (PubMed ID: 12499368)
1. DNA-dependent acetylation of p53 by the transcription coactivator p300.
Dornan D; Shimizu H; Perkins ND; Hupp TR
J Biol Chem; 2003 Apr; 278(15):13431-41. PubMed ID: 12499368
[TBL] [Abstract][Full Text] [Related]
2. The N-terminal interferon-binding domain (IBiD) homology domain of p300 binds to peptides with homology to the p53 transactivation domain.
Finlan L; Hupp TR
J Biol Chem; 2004 Nov; 279(47):49395-405. PubMed ID: 15337767
[TBL] [Abstract][Full Text] [Related]
3. The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53.
Dornan D; Shimizu H; Burch L; Smith AJ; Hupp TR
Mol Cell Biol; 2003 Dec; 23(23):8846-61. PubMed ID: 14612423
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of p53-dependent transcription by BOX-I phospho-peptide mimetics that bind to p300.
Dornan D; Hupp TR
EMBO Rep; 2001 Feb; 2(2):139-44. PubMed ID: 11258706
[TBL] [Abstract][Full Text] [Related]
5. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
[TBL] [Abstract][Full Text] [Related]
6. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage.
Liu L; Scolnick DM; Trievel RC; Zhang HB; Marmorstein R; Halazonetis TD; Berger SL
Mol Cell Biol; 1999 Feb; 19(2):1202-9. PubMed ID: 9891054
[TBL] [Abstract][Full Text] [Related]
7. Functional analysis of the p300 acetyltransferase domain: the PHD finger of p300 but not of CBP is dispensable for enzymatic activity.
Bordoli L; Hüsser S; Lüthi U; Netsch M; Osmani H; Eckner R
Nucleic Acids Res; 2001 Nov; 29(21):4462-71. PubMed ID: 11691934
[TBL] [Abstract][Full Text] [Related]
8. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.
Craig AL; Chrystal JA; Fraser JA; Sphyris N; Lin Y; Harrison BJ; Scott MT; Dornreiter I; Hupp TR
Mol Cell Biol; 2007 May; 27(9):3542-55. PubMed ID: 17339337
[TBL] [Abstract][Full Text] [Related]
9. E6 oncoprotein represses p53-dependent gene activation via inhibition of protein acetylation independently of inducing p53 degradation.
Thomas MC; Chiang CM
Mol Cell; 2005 Jan; 17(2):251-64. PubMed ID: 15664194
[TBL] [Abstract][Full Text] [Related]
10. p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300.
Livengood JA; Scoggin KE; Van Orden K; McBryant SJ; Edayathumangalam RS; Laybourn PJ; Nyborg JK
J Biol Chem; 2002 Mar; 277(11):9054-61. PubMed ID: 11782467
[TBL] [Abstract][Full Text] [Related]
11. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain.
Gu W; Roeder RG
Cell; 1997 Aug; 90(4):595-606. PubMed ID: 9288740
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
[TBL] [Abstract][Full Text] [Related]
13. DNA damage activates p53 through a phosphorylation-acetylation cascade.
Sakaguchi K; Herrera JE; Saito S; Miki T; Bustin M; Vassilev A; Anderson CW; Appella E
Genes Dev; 1998 Sep; 12(18):2831-41. PubMed ID: 9744860
[TBL] [Abstract][Full Text] [Related]
14. Transcription coactivator CBP has direct DNA binding activity and stimulates transcription factor DNA binding through small domains.
Song CZ; Keller K; Chen Y; Murata K; Stamatoyannopoulos G
Biochem Biophys Res Commun; 2002 Aug; 296(1):118-24. PubMed ID: 12147236
[TBL] [Abstract][Full Text] [Related]
15. MDMX inhibits the p300/CBP-mediated acetylation of p53.
Sabbatini P; McCormick F
DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of p53 serine 15 increases interaction with CBP.
Lambert PF; Kashanchi F; Radonovich MF; Shiekhattar R; Brady JN
J Biol Chem; 1998 Dec; 273(49):33048-53. PubMed ID: 9830059
[TBL] [Abstract][Full Text] [Related]
17. Minimal activators that bind to the KIX domain of p300/CBP identified by phage display screening.
Frangioni JV; LaRiccia LM; Cantley LC; Montminy MR
Nat Biotechnol; 2000 Oct; 18(10):1080-5. PubMed ID: 11017047
[TBL] [Abstract][Full Text] [Related]
18. P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1), paired-like homeoprotein, through acetylation of the conserved lysine residue adjacent to the homeodomain.
Iioka T; Furukawa K; Yamaguchi A; Shindo H; Yamashita S; Tsukazaki T
J Bone Miner Res; 2003 Aug; 18(8):1419-29. PubMed ID: 12929931
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a distinct inhibitory factor in the regulation of p53 functional activity.
Wiederschain D; Gu J; Yuan ZM
J Biol Chem; 2001 Jul; 276(30):27999-8005. PubMed ID: 11382762
[TBL] [Abstract][Full Text] [Related]
20. Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation.
Jenkins LM; Yamaguchi H; Hayashi R; Cherry S; Tropea JE; Miller M; Wlodawer A; Appella E; Mazur SJ
Biochemistry; 2009 Feb; 48(6):1244-55. PubMed ID: 19166313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]